Alkeran

In the US, Alkeran (melphalan systemic) is a member of the drug class alkylating agents and is used to treat Multiple Myeloma and Ovarian Cancer.

US matches:

• Alkeran


• Alkeran Tablets


• Alkeran I.V.


• Alkeran IV

UK matches:

• Alkeran Injection 50 mg (SPC)
• Alkeran Injection Diluent (SPC)

Ingredient matches for Alkeran

Melphalan

Melphalan is reported as an ingredient of Alkeran in the following countries:

• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Brazil


• Canada


• Chile


• Czech Republic


• Denmark


• Egypt


• Estonia


• Ethiopia


• Finland


• Germany


• Greece


• Guyana


• Hong Kong


• Iceland


• India


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Japan


• Jordan


• Kuwait


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Singapore


• Slovakia


• Slovenia


• South Africa


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Yemen

Melphalan hydrochloride (a derivative of Melphalan) is reported as an ingredient of Alkeran in the following countries:

• Chile


• Estonia


• Ireland


• Italy


• Lithuania


• Sweden


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.